EP2999450A1 - Obturateur d'un connecteur pour poche de perfusion - Google Patents
Obturateur d'un connecteur pour poche de perfusionInfo
- Publication number
- EP2999450A1 EP2999450A1 EP14731699.6A EP14731699A EP2999450A1 EP 2999450 A1 EP2999450 A1 EP 2999450A1 EP 14731699 A EP14731699 A EP 14731699A EP 2999450 A1 EP2999450 A1 EP 2999450A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- tubular body
- cap
- connector
- connector according
- perforable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1406—Septums, pierceable membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1475—Inlet or outlet ports
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1475—Inlet or outlet ports
- A61J1/1481—Inlet or outlet ports with connection retaining means, e.g. thread or snap-fit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2006—Piercing means
- A61J1/201—Piercing means having one piercing end
Definitions
- the invention relates to a connector for an infusion bag and an infusion bag provided with such a connector.
- the invention typically applies to containers for the intravenous administration of medical fluids to a patient.
- the invention applies to the infusion bag connectors.
- the flexible bags are generally made by welding a film or a flexible sheath. To allow access to the inside of the pocket, they are provided with one or more connectors, generally in the form of tubes. One of the connectors forms the injection site allowing the introduction into the bag of an additive such as a drug, and the other forms the infusion site for removing the solute from the bag by connecting a perforator.
- the perfusion site is adapted to receive the perforator of an infusion line and advantageously comprises a first perforable membrane and, at a distance from this first membrane, a second perforable membrane - said auto -rescient - which closes after removal of the perforator.
- This infusion site is also provided with a cap protecting the access to the self-resealing membrane until it is used.
- the injection site for the introduction of an additive into the bag is also provided with a self-resealing membrane which can be pierced by the needle of a syringe or a transfer device.
- EP 0 01 1 144 discloses a connector for infusion bag comprising a tube, a bowl placed in the tube, whose bottom forms a flat diaphragm and in which is arranged a membrane, and a breakable stopper.
- WO 2006/071781 discloses a connector system for an infusion bag, consisting of two types of ports: an addition port for connecting a needle and an administration port for connecting a perforator.
- the port of addition is formed of an assembly which comprises: (a) a closure body comprising an open cylinder in which is placed a flat diaphragm open to the flow of fluid once pierced by a needle, (b) a plug assembly comprising a shell surmounted by a removable plug, and (c) a self-resealing membrane placed between the closure body and the plug assembly which is mechanically held in the assembly.
- the administration port is formed of an assembly which comprises: (a) a second closure body comprising a sleeve whose upper portion is tapered so as to be able to connect different sizes of connectors, and (b) a second similar cap assembly to the plug assembly of the port of addition.
- US-4,632,673 discloses an injection or infusion site either directly welded to a wall of the pouch, or placed on the inlet or outlet tube of the pouch.
- the injection site is formed of a connector in the form of a tube on which or in which is disposed a pierceable rubber pellet.
- a flexible protective film is arranged under the pellet.
- Another flexible film forming a cap and provided with a tearable tab covers the pellet.
- the various elements of this connector are assembled by adhesion. These flexible films conform to the shape of the pellet but do not compress it, so that if adhesion is defective, tightness and sterility are no longer assured.
- the connector of the invention has a particular structure enabling it to ensure a good seal, especially during sterilization by steam.
- the invention proposes a connector for an infusion bag comprising at least a first tubular body forming an access orifice, said tubular body being equipped with a sleeve having a perforable transverse partition intended to ensure the tight closure of the access port, a perforable shutter sealingly disposed on said transverse partition, and a cap for compressing on the tubular body said perforable shutter mounted on said sleeve, the surface of said transverse partition in contact with the perforable shutter being curved so as to locally increase the compression of said perforable shutter between said cap and said tubular body.
- FIG. 1 represents a schematic view of an infusion bag equipped with a connector according to the invention.
- FIG. 2 represents a schematic and perspective view of the connector of FIG. 1.
- FIG. 3 represents a diagrammatic cross-sectional view of the connector of FIG. 2.
- FIG. 4 represents a schematic bottom view of the connector of FIG. 2.
- FIG. 5 represents a diagrammatic view in section along the axis AA identified in FIG. Figure 6 shows a schematic perspective and exploded view of the connector of Figure 2 and the various parts equipping it.
- FIG. 7 represents a schematic and sectional view of the first tubular body of the connector of FIG. 2.
- FIG. 8 represents a diagrammatic sectional view of the socket and the shutter of the connector of FIG. 2.
- FIG. 9 represents a schematic and partially sectional view of the connector cap of FIG. 2.
- Figure 10 shows a schematic cross-sectional view of the cap of the connector of Figure 2 locked in rotation on the tubular body.
- Figure 1 1 is a schematic sectional view of another embodiment of a connector, pierced by a perforator.
- FIG. 12 represents a diagrammatic sectional view of the socket and the shutter of the connector of FIG.
- upstream and downstream are defined relative to the flow direction of the fluid from the inside of the pocket to the outside.
- the invention relates to a connector for an infusion bag and an infusion bag comprising such a connector.
- the bag 1 is formed of two flexible sheets associated with each other along a peripheral seal 2.
- the bag is formed of a flexible sheet folded on itself or a flexible sheath.
- the bag is made in particular of a flexible and sterilizable thermoplastic material such as polyvinyl chloride, a polyolefin, ethylene vinyl acetate.
- a connector 3 disposed between the walls of the bag and comprising at least a first and second tubular body 4,5 each forming an access port to the inside volume of the pocket.
- the first tubular body 4 forms an infusion site adapted to receive the perforator of an infusion line for administering fluid contained in the bag to a patient.
- the second tubular body 5 forms an injection site adapted to allow the introduction of an additive, such as a drug solution, into the internal volume of the bag, via a syringe or a device transfer.
- the connector of the invention comprises at least a first and a second tubular body 4, each forming an access orifice, and a base 6 extending around said first and second tubular bodies , said base 6 being formed of a plate 7.
- the base 6 serves to support the tubular bodies 4,5 so as to form a unitary piece easily manipulated.
- the base 6 is formed of a plate 7, solid, thin and having a substantially flat surface.
- the plate 7 is arranged in a plane of symmetry of the tubular bodies 4,5.
- the thickness of the wafer 7 between the two tubular bodies 4,5 is in particular smaller than the outer diameter of the tubular bodies 4,5, generally of the order of one millimeter, in particular less than one millimeter.
- the thickness of the wafer 7 is for example of the order of 0.8 mm.
- the thickness of the wafer increases in the direction of the tubular bodies to a thickness substantially equal to that of the outer diameter of the tubular bodies, thus having, in cross-section with respect to the axis tubular bodies, the general shape of a tapered ellipse around said tubular bodies.
- This base 6 formed of a plate 7 allows the good bonding of the walls of the pocket 1, that is to say the crushing of the walls of the pocket against each other, at the connector 3, when emptying the pocket.
- a good collabage thus optimizes the complete emptying of the bag during an infusion to a patient.
- Thicker or hollow bases prevent the walls from collapsing at the connector, thus creating a retention zone of the fluid contained in the pocket.
- the wafer 7 comprises a welding zone 8 intended to be welded to the walls of an infusion bag and a gripping zone 9 which extends outside said welding zone between the first and second and second tubular body 4,5, said gripping area 9 having sufficient size and stiffness to allow gripping.
- the welding zone 8 corresponds to the area of the wafer 7 which will be placed between the walls of the infusion bag. As illustrated in FIG. 2, this welding zone is provided with welding ribs 10 in order to facilitate the welding of the walls of the pocket on the connector 3.
- the welding ribs 10 are arranged over the entire length of the wafer, perpendicular to the axis of the tubular bodies 4,5.
- the thickness of the welding ribs 10 is of the order of 0.5 mm.
- the number of welding ribs depends on the size of the welding zone 8 and the size of said ribs 10.
- FIG. 2 four welding ribs 10 are shown.
- the thickness of the welding ribs 10 increases towards the tubular bodies 4,5, thus having a cross-sectional relation to the to the axis of the tubular bodies 4,5, the general shape of an ellipse tapered around said bodies ( Figure 4).
- each transverse end of the wafer 7 forming the base 6 is extended by a tongue January 1.
- These tongues January 1 have a reduced thickness relative to that of the wafer 7, for example of the order of 0.25 mm.
- These tongues 1 1 improve the welding of the walls of the infusion bag on the connector 3.
- the gripping zone 9 of the wafer 7 extends the welding zone 8.
- This gripping zone 9 is in particular full, that is to say that it does not have an aperture.
- This gripping zone 9 allows a user to enter the pocket 1 between his fingers. During the manufacture of the pocket, this gripping zone 9 can also be grasped by a machine to automate the manufacture. In addition, this gripping zone 9 limits the fragility of the connector generated by the fineness of the base.
- the gripping zone 9 is provided with gripping ribs 12. These gripping ribs 12 extend perpendicularly to the axis of the tubular bodies 4,5.
- gripping ribs 12 for example four in number, have a thickness less than that of the welding ribs 10.
- the gripping ribs 12 have a thickness of the order of 0.25 mm.
- a reinforcing element 13 is arranged in the gripping zone 9 away from the welding zone 8 of the wafer 7. This reinforcing element is positioned between the two tubular bodies 4, perpendicular to the axis of each of the tubular bodies 4,5. This positioning thus limits the deformation of the connector 3 in the plane defined by the axes of the tubular bodies. This reinforcing element 13, in cooperation with the gripping zone 9, prevents the deformation of the connector 3 and in particular the tubular bodies 4,5 during the transport, storage, welding and sterilization steps.
- the base 6 being formed of a plate 7, and therefore being substantially thin, it is fragile and can break or easily deform.
- This reinforcing element 13 increases the strength of the connector 3.
- this reinforcing element 13 allows a machine to correctly and reproducibly position the connector 3 in position. view of its welding to the walls of the infusion bag.
- the reinforcing element 13 is in the form of a reinforcing rib.
- the reinforcing rib has a thickness of the order of 1.8 mm.
- each of the faces of the wafer 7 forming the base 6 comprises welding ribs 10, gripping ribs 12 and a reinforcing rib 13.
- the connector comprises a first tubular body 4 and a second tubular body 5, each forming an access port to the interior volume of the pocket.
- the first tubular body 4, in particular forming an infusion site, is equipped with a sleeve 14 having a perforable transverse partition 15 intended to seal the access orifice, a perforable shutter 16 arranged in a sealed manner on said transverse partition 15, and a cap 17 for compressing on the tubular body 4 said perforable shutter 16 mounted on said sleeve 14.
- the bushing comprises a flange 18 compressed on the edge of the first tubular body 4.
- the bushing 14 is formed of a substantially cylindrical element having at its downstream end the flange 18 directed towards the outside of the socket 14.
- the transverse wall 15 of the bushing 14 is located in particular in the downstream portion of said bushing 14, in particular at the downstream end.
- the curved transverse partition extends outwardly of the bushing to form said flange 18.
- This bushing 14 is mounted in force inside the first tubular body 4, the flange 18 of the bushing resting on the downstream end of said first tubular body 4.
- the transverse partition 15 of the bushing 14 hermetically closes the first body tubular 4 so as to prevent, before perforation, the passage of the fluid contained in the pocket to the outside of said pocket.
- the upstream portion of the bushing 14, before assembly in the first tubular body 4 is flared, that is to say that the upstream outside diameter of the bushing 14 is slightly greater than its downstream outside diameter.
- the transverse partition 15 is perforable, in particular by a perforator 36 as shown in FIG. 11, or by a cannula.
- the transverse partition 15 is in the form of a thin wall, of the order of 0.25 mm, made of the same material as the cylindrical element of the sleeve 14.
- the perforable shutter 16 is sealingly disposed on the transverse wall 15 of the socket, that is to say on the downstream side of the partition.
- the transverse partition 15, before perforation also prevents the direct contact of the fluid contained in the infusion bag with the perforable shutter 16.
- the perforable shutter 16 comprises a membrane of elastomer, rubber or other similar material, which can be traversed by a perforator and close by itself once the perforator has been removed.
- the perforator is for example that of a perfusor.
- the perforable shutter 16 has a substantially cylindrical body of relatively small height relative to the diameter.
- the body has a shoulder bearing on the flange 18 of the sleeve 14 when the perforable shutter 16 is mounted in said sleeve.
- the transverse wall 21 of the cap 17 compresses the pierceable shutter
- the central portion of the downstream surface of said body has a disk-shaped scar slightly curved towards the inside of the sleeve 14. And, according to the invention, the upstream surface of said body is substantially curved.
- the sleeve 14 and the perforable shutter 16 form a unitary piece.
- the bushing 14 and the perforable shutter 16 are welded together in an inseparable manner.
- the bushing 14 and the perforable shutter 16 are formed by bi-injection molding.
- the first tubular body 4 is also equipped with a cap 17 for compressing said perforable shutter 16 and said sleeve 14 on the tubular body 4. As shown in FIG. 3, the cap 17 covers said first tubular body 4.
- first tubular body 4 and the cap 17 have complementary latching projections 19,20, shown in particular in FIG. 3.
- the cap 17 is formed of a transverse wall 21 extending into a peripheral skirt 22, visible in FIG.
- the transverse wall 21 crushes the perforable shutter 16 in order to keep it firmly clamped in said first tubular body 4.
- the cap 17 has an opening 23 arranged to allow the introduction of a perforator into the shutter.
- the opening 23 is arranged in the transverse wall 21 of the cap 17 as shown in FIGS. 9 and 11.
- the surface of the transverse partition 15 of the sleeve 14 in contact with the perforable shutter 16 is curve so as to locally increase the compression of said perforable shutter 16 between said cap 17 and said tubular body 4, especially during the perforation.
- the curved shape increases the compression of the part of the perforable shutter 16 which is arranged between the transverse wall 21 of the cap 17 and the flange 18 of the sleeve 14.
- the shape of the transverse partition 15 is not straight, but curved, that is to say that the central zone of the transverse partition 15 is not at the same level as the peripheral zone of said transverse partition 15.
- This curved shape of the transverse partition 15 in close contact with the perforable shutter 16 will increase the vertical stress exerted by the cap 17 on the perforable shutter 16 during placement of the cap 17 on the first tubular body 4.
- the surface of said transverse partition 15 is curved towards the inside of the bushing 14, that is to say upstream.
- the transverse septum 15 is convex when the infusion bag is used, i.e., when the bag is disposed so that the fluid in the bag flows from the inside of the outside.
- the surface of said transverse partition 15 is curved outwardly of the sleeve 14, that is to say downstream.
- the transverse septum is concave when the infusion bag is used, i.e., when the bag is disposed for the fluid in the bag to flow from the inside of the outside.
- the perforable shutter 16 is sealingly disposed on the transverse partition 15 of the sleeve 14
- the surface of the perforable shutter 16 in contact with the transverse partition 15 has a curved complementary shape.
- the surface of the perforable shutter 16 in contact with the cap 17 and in particular the transverse wall 21 of the cap 17 is flat.
- the perforable shutter 16 is thus substantially plano-convex or plane-concave.
- the seal between the cap 17 and the perforable shutter 16 is further increased when the sleeve 14 has a flared shape as defined above.
- the connector 3 further comprises a plug 24 having a weak zone 25 associated with the cap 17, said zone of weakness 25 being arranged to be broken by a manual action so as to separate the plug 24 from said cap 17 and allow access to the opening of the cap 17.
- the plug 24 protects the perforable shutter 16 until the user wishes to perforate said shutter by a perforator.
- the zone of weakness 25 of the stopper 24 can be broken during a lateral or rotational load.
- the first tubular body 4 is advantageously rigid in order to avoid being deformed or twisted when opening the stopper 24.
- the plug 24 comprises a pallet 26 of shape and size sufficient for a user to grasp it between his fingers.
- the zone of weakness 25 is broken by exerting a rotational movement or a lateral movement on this pallet 26, making accessible the opening 23 of the cap 17 and therefore the pierceable shutter 16.
- the zone of weakness 25 is, for example, a zone of small thickness, for example of the order of 0.1 mm.
- the first tubular body 4 has on its outer surface a collar 27 with respect to which the cap 17 is arranged.
- the cap 17 is locked in rotation on the tubular body 4.
- the tubular body 4 has axial fins 28 distributed on its external surface which engage in corresponding ridges 29 arranged on the inner surface of the cap 17, so as to lock in rotation the cap 17 on the tubular body 4.
- the fins 28 are in particular arranged between the flange 27 and the snap-fitting projection 19 of the first body
- the fins 28 are in contact with said flange 27.
- the number of fins 28 is between 1 and 10, in particular 8. These fins 28 engage in streaks 29 provided on the inner surface of the cap 17.
- the number of ridges 29 is equal to or greater than the number of fins 28.
- the second tubular body 5 forming in particular an injection site, is equipped with a tip 30 and a perforable shutter 31 sealingly disposed in said tip 30.
- the second tubular body 5 is advantageously flexible to allow manual or automatic clamping to control the introduction of an additive into the pocket.
- the second tubular body is equipped with a shutter type "nail cap" (not shown).
- the tip 30 has an upstream cylindrical portion 32 and a downstream cylindrical portion 33, the upstream portion 32 being intended to be introduced in a sealed manner into the second tubular body 5 and the downstream portion 33, of outside diameter slightly greater than the outside diameter of the upstream portion 32 remains outside said second tubular body 5 while resting on the edge of said second tubular body 5.
- the inside diameter of the upstream portion 32 is advantageously smaller than the inside diameter of the downstream portion 33 so as to create a bearing surface 34 on which the perforable shutter 31 rests.
- the perforable shutter 31 of the second tubular body 5 comprises an elastomeric membrane, rubber or other similar material, which can be traversed by a needle and close on its own once the needle has been removed.
- the needle is for example that of a syringe containing a drug solution to be added to the fluid contained in the infusion bag or that of a transfer device for transferring the drug content of a vial into said infusion bag.
- the second tubular body 5 is provided with a transverse and perforable wall 35, intended to ensure the tight closure of the second tubular body 5, sealingly closing said tubular body 5 to the perforation of said partition 35.
- the partition 35 of the second tubular body 5 is located near the upstream end of said tip 30.
- the assembly of such a connector 3 is particularly easy and requires only a few steps.
- the various parts constituting the connector are molded and mechanically assembled.
- injection molding is carried out on the one hand by a connector 3 comprising a first and second tubular body 4,5 and a base 6 extending around said first and second bodies 4,5 as described above and represented on Figure 6 and secondly, the cap 17 provided with a plug 24.
- the sleeve 14 and the perforable shutter 16 are made in one piece by bi-injection molding.
- the injection site is assembled by inserting the tip 30 provided with a perforable shutter 31 in the second tubular body 5.
- the connector is sterilized, especially by heat.
- the various parts of the connector 3 are thermally welded during this sterilization step, thus providing a fully sealed connector and easy to weld.
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1354584A FR3005855B1 (fr) | 2013-05-22 | 2013-05-22 | Obturateur d'un connecteur pour poche de perfusion |
PCT/FR2014/051194 WO2014188128A1 (fr) | 2013-05-22 | 2014-05-21 | Obturateur d'un connecteur pour poche de perfusion |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2999450A1 true EP2999450A1 (fr) | 2016-03-30 |
EP2999450B1 EP2999450B1 (fr) | 2018-10-31 |
Family
ID=48980041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP14731699.6A Active EP2999450B1 (fr) | 2013-05-22 | 2014-05-21 | Obturateur d'un connecteur pour poche de perfusion |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2999450B1 (fr) |
FR (1) | FR3005855B1 (fr) |
WO (1) | WO2014188128A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3721853A4 (fr) * | 2017-12-07 | 2021-09-08 | Fujimori Kogyo Co., Ltd. | Sac muni d'un orifice et sac muni d'un capuchon |
CN118647354A (zh) * | 2022-02-04 | 2024-09-13 | 费森尤斯卡比德国有限公司 | 输液袋及其制造方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1202997A (fr) * | 1958-04-22 | 1960-01-14 | Obturation à refermeture spontanée pour tous flacons ou poches, principalement médicaux, en matière plastique | |
DE7832028U1 (de) * | 1978-10-27 | 1979-04-19 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Verschluss fuer einen plastikinfusionsloesungsbeutel |
US4632673A (en) * | 1983-06-15 | 1986-12-30 | Hantaaki Oy | Pierceable port for containers |
US6113583A (en) * | 1998-09-15 | 2000-09-05 | Baxter International Inc. | Vial connecting device for a sliding reconstitution device for a diluent container |
DE10223560B4 (de) | 2002-05-27 | 2006-01-19 | Fresenius Kabi Deutschland Gmbh | Konnektor für medizinische Flüssigkeiten enthaltende Verpackungen und Verpackung für medizinische Flüssigkeiten |
WO2006071781A2 (fr) | 2004-12-23 | 2006-07-06 | Hospira, Inc. | Systeme de fermeture d'orifices pour recipient de fluide intraveineux |
-
2013
- 2013-05-22 FR FR1354584A patent/FR3005855B1/fr active Active
-
2014
- 2014-05-21 EP EP14731699.6A patent/EP2999450B1/fr active Active
- 2014-05-21 WO PCT/FR2014/051194 patent/WO2014188128A1/fr active Application Filing
Non-Patent Citations (1)
Title |
---|
See references of WO2014188128A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP2999450B1 (fr) | 2018-10-31 |
FR3005855A1 (fr) | 2014-11-28 |
FR3005855B1 (fr) | 2015-06-26 |
WO2014188128A1 (fr) | 2014-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1226077B1 (fr) | Dispositif de connexion pret a l'emploi | |
EP2394932B1 (fr) | Capsule à zone d'amorce de rupture | |
FR2780878A1 (fr) | Capuchon de transfert encliquetable | |
EP0732114A1 (fr) | Dispositif de perforation et ensemble de raccordement pour système d'alimentation par voie entérale et procédé de raccordement | |
CA2920809C (fr) | Bouchon pour receptacle et receptacle, notamment tube, en particulier tube souple pour produit cosmetique, muni dudit bouchon | |
WO1999006007A1 (fr) | Dispositif de compartimentation d'un biberon pour bebe | |
FR2828679A1 (fr) | Tube souple a tete distributrice sans retour d'air | |
EP2999450B1 (fr) | Obturateur d'un connecteur pour poche de perfusion | |
EP3105488A1 (fr) | Ensemble de raccordement fluidique modulaire. | |
WO2021053237A1 (fr) | Connecteur monobloc pour poche de perfusion souple | |
FR2889461A1 (fr) | Microtube de laboratoire. | |
EP2253298B1 (fr) | Connecteur pour récipient souple destiné à contenir un liquide médical | |
CA2645614C (fr) | Dispositif de preparation d'un produit pharmaceutique ou medicamenteux injectable | |
WO2014188126A1 (fr) | Embase d'un connecteur pour poche de perfusion | |
FR2665633A1 (fr) | Perfectionnements aux recipients a contenu sterile, notamment aux poches souples a usage medical. | |
CA2470224A1 (fr) | Embout perfuseur pour poche souple a usage medical | |
EP2388042B1 (fr) | Connecteur pour un circuit de liquide | |
EP2146923B1 (fr) | Coiffe de fermeture pour conteneur adapté pour le stockage de liquides carbonates, et conteneur pourvu d'une telle coiffe | |
FR2948289A1 (fr) | Port d'injection et recipient a usage medical equipe d'au moins un tel port | |
EP0780316A1 (fr) | Récipient manipulable en matière plastique | |
FR2742733A1 (fr) | Recipient manipulable en matiere plastique | |
EP4051601A1 (fr) | Surbouchon de sécurité pour récipient | |
FR2732317A1 (fr) | Dispositif d'acces a une poche en matiere synthetique souple | |
EP3621893A1 (fr) | Bague d'espacement destinee a etre positionnee entre un receptacle et un bouchon et ensemble dudit receptacle et de ladite bague | |
FR3026390A1 (fr) | Dispositif de fermeture d'un conteneur et conteneur muni dudit dispositif. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20151120 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20170913 |
|
GRAJ | Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
INTC | Intention to grant announced (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20180523 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1058512 Country of ref document: AT Kind code of ref document: T Effective date: 20181115 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602014035097 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: FRENCH |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20181031 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1058512 Country of ref document: AT Kind code of ref document: T Effective date: 20181031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190131 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190131 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190228 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190201 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190301 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602014035097 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20190801 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190531 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190531 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190521 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190521 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20140521 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20230531 Year of fee payment: 10 Ref country code: DE Payment date: 20230620 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20230531 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20230622 Year of fee payment: 10 |